General Information
Revision date
2020-07-21
Product name
Tacrolimus Capsules, USP
Manufacturer Name
Concord Biotech Limited
Icons in SDS
Company Information
company name
Lupin Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Tacrolimus capsules are contraindicated in patients with a hypersensitivity to tacrolimus. Tacrolimus injection is contraindicated in patients with a hypersensitivity to HCO-60 (polyoxyl 60 hydrogenated castor oil). Hypersensitivity symptoms reported include dyspnea, rash, pruritus, and acute respiratory distress syndrome.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
